Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2ASizun Jiang, Bradford Willox, Hufeng Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZDeo R Singh, Scott E Nelson, Abigail S Pawelski, et al.
Cancer Immunology Research|November 14, 2025
CD8+ T cell antitumor immunity via human iNKT-DC conjugatesDana C Baiu, Kelsey A Smith, Sarah A Ferguson, et al.
Plos Pathogens|August 21, 2018
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse modelJames C Romero-Masters, Makoto Ohashi, Reza Djavadian, et al.
Plos Pathogens|April 15, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceJillian A Bristol, Scott E Nelson, Makoto Ohashi, et al.
Plos Pathogens|November 8, 2021
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cellsNicholas Van Sciver, Makoto Ohashi, Dhananjay M Nawandar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expressionChunyan Wang, Jillian A Bristol, Scott E Nelson, et al.
Plos Pathogens|April 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsJillian A Bristol, Joshua Brand, Makoto Ohashi, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Pageof 3